antiretroviral therapies HIV-1 pregnancy | News | Harvard T.H. Chan School of Public Health

Dolutegravir-based antiretroviral therapies for HIV-1 effective in pregnancy

Related Keywords

Boston ,Massachusetts ,United States ,Switzerland ,Swiss ,Deborah Kacanek ,George Seage ,Leila Sultan Beyer ,Lynnm Yee ,Elleng Chadwick ,Paigel Williams ,Kathleenm Powis ,Jennifer Jao ,Yanling Huo ,Stephanie Shiau ,Kunjal Patel ,Georger Seage ,Rebecca Zash ,Seans Brummel ,Paige Williams ,Harvard Chan ,Christianr Kahlert ,Denise Jacobson ,Denisel Jacobson ,Sean Brummel ,National Institute On Drug Abuse ,Harvard Chan School ,Department Of Epidemiology At Harvard Chan School ,National Cancer Institute ,National Institute Of Allergy ,National Institute Of Mental Health ,Swiss National Science Foundation ,Blood Institute ,Craniofacial Research ,National Heart ,National Institute Of Neurological Disorders ,Human Development ,National Institutes Of Health ,National Institute On Deafness ,National Institute On Alcohol Abuse ,Public Health ,Eunice Kennedy Shriver National Institute ,Child Health ,National Institutes ,National Institute ,Infectious Diseases ,Neurological Disorders ,Mental Health ,Drug Abuse ,Alcohol Abuse ,